Anacor Pharmaceuticals Inc (ANAC.OQ)

ANAC.OQ on NASDAQ Stock Exchange Global Market

27.66USD
22 Oct 2014
Price Change (% chg)

$-0.58 (-2.05%)
Prev Close
$28.24
Open
$28.26
Day's High
$28.44
Day's Low
$27.26
Volume
125,857
Avg. Vol
155,937
52-wk High
$28.44
52-wk Low
$11.34

ANAC.OQ

Chart for ANAC.OQ

About

Anacor Pharmaceuticals Inc is a United States-based biopharmaceutical company focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. The Company’s product candidates include topically administered dermatologic compounds-tavaborole (formerly AN2690), a topical... (more)

Overall

Beta: 1.53
Market Cap (Mil.): $1,185.96
Shares Outstanding (Mil.): 42.00
Dividend: --
Yield (%): --

Financials

  ANAC.OQ Industry Sector
P/E (TTM): 20.67 139.94 33.54
EPS (TTM): 1.37 -- --
ROI: 87.34 -1.53 17.61
ROE: 156.72 -6.70 18.42
Search Stocks

FDA approves Anacor Pharma's drug for nail infection

- Anacor Pharmaceutical Inc said the U.S. Food and Drug Administration approved its treatment for a fungal infection of the toenail.

08 Jul 2014

UPDATE 1-FDA approves Anacor Pharma's drug for nail infection

July 8 - Anacor Pharmaceutical Inc said the U.S. Food and Drug Administration approved its treatment for a fungal infection of the toenail.

08 Jul 2014

FDA approves Anacor Pharma's drug for nail infection

July 8 - Anacor Pharmaceutical Inc said the U.S. Food and Drug Administration approved its treatment for a fungal infection of the nail, sending the drug developer's shares up about 9 percent in premarket trade.

08 Jul 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks